213 related articles for article (PubMed ID: 30910406)
1. Systematic review of health economic evaluation studies of dengue vaccines.
de Soárez PC; Silva AB; Randi BA; Azevedo LM; Novaes HMD; Sartori AMC
Vaccine; 2019 Apr; 37(17):2298-2310. PubMed ID: 30910406
[TBL] [Abstract][Full Text] [Related]
2. The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review.
Endo IC; Ziegelmann PK; Patel A
Vaccine; 2016 Dec; 34(50):6133-6147. PubMed ID: 27810313
[TBL] [Abstract][Full Text] [Related]
3. Current issues in the economics of vaccination against dengue.
Tozan Y
Expert Rev Vaccines; 2016; 15(4):519-28. PubMed ID: 26642099
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Dengue Vaccination Programs in Brazil.
Shim E
Am J Trop Med Hyg; 2017 May; 96(5):1227-1234. PubMed ID: 28500811
[TBL] [Abstract][Full Text] [Related]
5. Economic Evaluations of Dengue Vaccination in the Southeast Asia Region: Evidence From a Systematic Review.
Supadmi W; Suwantika AA; Perwitasari DA; Abdulah R
Value Health Reg Issues; 2019 May; 18():132-144. PubMed ID: 31082793
[TBL] [Abstract][Full Text] [Related]
6. Dengue dynamics and vaccine cost-effectiveness in Brazil.
Durham DP; Ndeffo Mbah ML; Medlock J; Luz PM; Meyers LA; Paltiel AD; Galvani AP
Vaccine; 2013 Aug; 31(37):3957-61. PubMed ID: 23791696
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of dengue vaccination in ten endemic countries.
Zeng W; Halasa-Rappel YA; Baurin N; Coudeville L; Shepard DS
Vaccine; 2018 Jan; 36(3):413-420. PubMed ID: 29229427
[TBL] [Abstract][Full Text] [Related]
8. Vaccines are different: A systematic review of budget impact analyses of vaccines.
Loze PM; Nasciben LB; Sartori AMC; Itria A; Novaes HMD; de Soárez PC
Vaccine; 2017 May; 35(21):2781-2793. PubMed ID: 28427846
[TBL] [Abstract][Full Text] [Related]
9. The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling.
Shafie AA; Yeo HY; Coudeville L; Steinberg L; Gill BS; Jahis R; Amar-Singh Hss
Pharmacoeconomics; 2017 May; 35(5):575-589. PubMed ID: 28205150
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore.
Carrasco LR; Lee LK; Lee VJ; Ooi EE; Shepard DS; Thein TL; Gan V; Cook AR; Lye D; Ng LC; Leo YS
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1426. PubMed ID: 22206028
[TBL] [Abstract][Full Text] [Related]
11. Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines.
Shim E
Am J Trop Med Hyg; 2016 Nov; 95(5):1137-1147. PubMed ID: 27601519
[TBL] [Abstract][Full Text] [Related]
12. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.
Augustovski F; Iglesias C; Manca A; Drummond M; Rubinstein A; Martí SG
Pharmacoeconomics; 2009; 27(11):919-29. PubMed ID: 19888792
[TBL] [Abstract][Full Text] [Related]
13. Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.
Douglas DL; DeRoeck DA; Mahoney RT; Wichmann O
PLoS Negl Trop Dis; 2013; 7(3):e2127. PubMed ID: 23516658
[TBL] [Abstract][Full Text] [Related]
14. Projected Impact of Dengue Vaccination in Yucatán, Mexico.
Hladish TJ; Pearson CA; Chao DL; Rojas DP; Recchia GL; Gómez-Dantés H; Halloran ME; Pulliam JR; Longini IM
PLoS Negl Trop Dis; 2016 May; 10(5):e0004661. PubMed ID: 27227883
[TBL] [Abstract][Full Text] [Related]
15. Updated recommendations of the International Dengue Initiative expert group for CYD-TDV vaccine implementation in Latin America.
Torres JR; Falleiros-Arlant LH; Gessner BD; Delrieu I; Avila-Aguero ML; Giambernardino HIG; Mascareñas A; Brea J; Torres CN; Castellanos-Martinez JM
Vaccine; 2019 Oct; 37(43):6291-6298. PubMed ID: 31515144
[TBL] [Abstract][Full Text] [Related]
16. Economic value of dengue vaccine in Thailand.
Lee BY; Connor DL; Kitchen SB; Bacon KM; Shah M; Brown ST; Bailey RR; Laosiritaworn Y; Burke DS; Cummings DA
Am J Trop Med Hyg; 2011 May; 84(5):764-72. PubMed ID: 21540387
[TBL] [Abstract][Full Text] [Related]
17. Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil.
Campolina AG; Rozman LM; Decimoni TC; Leandro R; Novaes HM; De Soárez PC
Appl Health Econ Health Policy; 2017 Apr; 15(2):163-172. PubMed ID: 27798797
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of health economic evaluations of vaccines in Brazil.
Sartori AMC; Rozman LM; Decimoni TC; Leandro R; Novaes HMD; de Soárez PC
Hum Vaccin Immunother; 2017 Jun; 13(6):1-12. PubMed ID: 28129026
[TBL] [Abstract][Full Text] [Related]
19. Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine.
Godói IP; Da Silva LVD; Sarker AR; Megiddo I; Morton A; Godman B; Alvarez-Madrazo S; Bennie M; Guerra-Junior AA
Expert Rev Vaccines; 2018 Dec; 17(12):1123-1133. PubMed ID: 30417706
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of dengue vaccination in Puerto Rico.
España G; Leidner AJ; Waterman SH; Perkins TA
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009606. PubMed ID: 34310614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
